PERCEPTIVE ADVISORS LLC Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$7.9B
Holdings
137
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (137 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRTXEURMIRATI THERAPEUTICS INC | 3,474,505 | $595.2B | 7521.44% | |
| 2 | BBIOBRIDGEBIO PHARMA INC | 7,756,928 | $477.8B | 6038.39% | |
| 3 | TVTX 2.5 09/15/25RETROPHIN INC | 45,000,000 | $474.8B | 5999.51% | |
| 4 | BIIBBIOGEN INC | 1,348,000 | $377.1B | 4765.52% | Put |
| 5 | SWTXSPRINGWORKS THERAPEUTICS INC | 4,849,912 | $356.8B | 4509.05% | |
| 6 | IOVAIOVANCE BIOTHERAPEUTICS INC | 8,651,785 | $273.9B | 3461.52% | |
| 7 | AM6AMICUS THERAPEUTICS INC | 22,861,329 | $225.9B | 2854.36% | |
| 8 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 5,058,642 | $206.1B | 2605.02% | |
| 9 | NVTA1EURINVITAE CORP | 5,360,673 | $204.8B | 2588.49% | |
| 10 | —COLLEGIUM PHARMACEUTICAL INC | 17,500,000 | $189.6B | 2395.51% | |
| 11 | HZNPHORIZON THERAPEUTICS PUB L | 2,050,002 | $188.7B | 2384.41% | |
| 12 | AVIRATEA PHARMACEUTICALS INC | 3,109,224 | $184.7B | 2334.00% | |
| 13 | VAC2USDVBI VACCINES INC CDA | 55,042,465 | $171.2B | 2163.26% | |
| 14 | —LANDOS BIOPHARMA INC | 17,960,839 | $159.7B | 2018.01% | |
| 15 | —ZYMEWORKS INC | 4,330,868 | $136.8B | 1728.38% | |
| 16 | NVRO 2.75 04/01/25NEVRO CORP | 9,000,000 | $135.3B | 1710.12% | |
| 17 | OMGBPOUTSET MED INC | 2,387,535 | $129.9B | 1641.04% | |
| 18 | RCKTROCKET PHARMACEUTICALS INC | 2,867,771 | $127.2B | 1607.99% | |
| 19 | CCCCC4 THERAPEUTICS INC | 3,158,566 | $116.8B | 1476.47% | |
| 20 | NVROEURNEVRO CORP | 812,154 | $113.3B | 1431.73% | |
| 21 | ALDXALDEYRA THERAPEUTICS INC | 8,703,879 | $103.4B | 1306.71% | |
| 22 | MGTXMEIRAGTX HLDGS PLC | 6,933,277 | $93.4B | 1179.99% | |
| 23 | NBIXNEUROCRINE BIOSCIENCES INC | 941,832 | $91.6B | 1157.48% | |
| 24 | BDQMALBIREO PHARMA INC | 2,360,139 | $83.2B | 1051.35% | |
| 25 | TVTXTRAVERE THERAPEUTICS INC | 3,298,419 | $82.4B | 1040.82% | |
| 26 | KRON1USDKRONOS BIO INC | 2,780,097 | $79.7B | 1006.82% | |
| 27 | SLDBSOLID BIOSCIENCES INC | 13,412,552 | $74.2B | 937.31% | |
| 28 | RLAYRELAY THERAPEUTICS INC | 2,018,097 | $69.8B | 881.65% | |
| 29 | CHRSCOHERUS BIOSCIENCES INC | 4,697,612 | $68.6B | 867.32% | |
| 30 | MGNXMACROGENICS INC | 2,148,060 | $68.4B | 864.59% | |
| 31 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 4,643,095 | $63.7B | 805.61% | |
| 32 | —ATHIRA PHARMA INC | 3,425,916 | $63.0B | 796.61% | |
| 33 | ESTAESTABLISHMENT LABS HLDGS INC | 987,287 | $61.7B | 780.16% | |
| 34 | —KADMON HLDGS INC | 15,711,334 | $61.1B | 772.35% | |
| 35 | NARIUSDINARI MED INC | 565,113 | $60.5B | 764.13% | |
| 36 | —QUOTIENT LTD | 16,200,818 | $59.6B | 753.42% | |
| 37 | MORFMORPHIC HLDG INC | 938,140 | $59.4B | 750.21% | |
| 38 | ATNXEURATHENEX INC | 13,532,467 | $57.3B | 724.49% | |
| 39 | —PROMETHEUS BIOSCIENCES INC | 3,314,032 | $55.4B | 699.52% | |
| 40 | RAPTEURRAPT THERAPEUTICS INC | 2,477,481 | $55.0B | 695.05% | |
| 41 | VRCAVERRICA PHARMACEUTICALS INC | 3,610,412 | $54.7B | 691.23% | |
| 42 | CRNXCRINETICS PHARMACEUTICALS IN | 3,659,381 | $51.6B | 652.16% | |
| 43 | VERUEURVERU INC | 4,451,342 | $48.0B | 606.12% | |
| 44 | EXASEXACT SCIENCES CORP | 353,523 | $46.6B | 588.73% | |
| 45 | MNLOUSDVYNE THERAPEUTICS INC | 6,773,954 | $46.4B | 585.96% | |
| 46 | KODKODIAK SCIENCES INC | 389,008 | $44.1B | 557.43% | |
| 47 | TARSTARSUS PHARMACEUTICALS INC | 1,296,416 | $41.1B | 519.73% | |
| 48 | —DBV TECHNOLOGIES S A | 7,695,505 | $41.0B | 518.34% | |
| 49 | ALLOALLOGENE THERAPEUTICS INC | 1,143,790 | $40.4B | 510.24% | |
| 50 | ARNAEURARENA PHARMACEUTICALS INC | 575,007 | $39.9B | 504.22% | |
| 51 | BEAMBEAM THERAPEUTICS INC | 537,635 | $37.8B | 478.09% | |
| 52 | LYRALYRA THERAPEUTICS INC | 3,222,560 | $37.3B | 471.99% | |
| 53 | ACADACADIA PHARMACEUTICALS INC | 1,410,305 | $36.4B | 459.82% | |
| 54 | —FORMA THERAPEUTICS HOLDINGS | 1,250,000 | $35.0B | 442.62% | |
| 55 | —AGILE THERAPEUTICS INC | 15,919,925 | $33.1B | 418.46% | |
| 56 | PRVBUSDPROVENTION BIO INC | 2,852,058 | $29.9B | 378.26% | |
| 57 | CMPSCOMPASS PATHWAYS PLC | 797,404 | $29.4B | 371.03% | |
| 58 | UTHUNITED THERAPEUTICS CORP DEL | 175,000 | $29.3B | 369.92% | |
| 59 | ADMAADMA BIOLOGICS INC | 16,584,802 | $29.2B | 368.87% | |
| 60 | NUVBNUVATION BIO INC | 3,041,004 | $29.0B | 367.00% | |
| 61 | OPHTEURIVERIC BIO INC | 4,585,512 | $28.3B | 358.11% | |
| 62 | IMTXIMMATICS N.V | 2,500,000 | $28.0B | 354.16% | |
| 63 | COGTCOGENT BIOSCIENCES INC | 3,188,750 | $28.0B | 353.80% | |
| 64 | —ONCORUS INC | 1,989,987 | $27.7B | 350.05% | |
| 65 | ARWRARROWHEAD PHARMACEUTICALS IN | 409,341 | $27.1B | 343.01% | |
| 66 | STOKSTOKE THERAPEUTICS INC | 671,978 | $26.1B | 329.83% | |
| 67 | ATECALPHATEC HOLDINGS INC | 1,800,180 | $25.5B | 322.12% | |
| 68 | PMVPPMV PHARMACEUTICALS INC | 746,557 | $24.6B | 310.29% | |
| 69 | VRNAVERONA PHARMA PLC | 2,888,889 | $24.2B | 305.20% | |
| 70 | RNAAVIDITY BIOSCIENCES INC | 1,099,028 | $24.0B | 302.91% | |
| 71 | HCATHEALTH CATALYST INC | 506,084 | $23.7B | 299.12% | |
| 72 | TOCAEURFORTE BIOSCIENCES INC | 685,000 | $23.5B | 296.66% | |
| 73 | COLLCOLLEGIUM PHARMACEUTICAL INC | 978,277 | $23.2B | 292.99% | |
| 74 | —FUSION PHARMACEUTICALS INC | 1,950,167 | $20.9B | 264.18% | |
| 75 | —DICERNA PHARMACEUTICALS INC | 800,000 | $20.5B | 258.51% | |
| 76 | —1LIFE HEALTHCARE INC | 519,844 | $20.3B | 256.72% | |
| 77 | MREOMEREO BIOPHARMA GROUP PLC | 6,000,000 | $20.2B | 255.52% | |
| 78 | —FREQUENCY THERAPEUTICS INC | 2,113,661 | $20.1B | 253.75% | |
| 79 | FDMT4D MOLECULAR THERAPEUTICS IN | 444,878 | $19.3B | 243.87% | |
| 80 | SILKSILK RD MED INC | 340,100 | $17.2B | 217.69% | |
| 81 | IMCRIMMUNOCORE HLDGS PLC | 400,000 | $17.0B | 215.19% | |
| 82 | PCVXVAXCYTE INC | 850,000 | $16.8B | 212.14% | |
| 83 | CTMXCYTOMX THERAPEUTICS INC | 2,153,974 | $16.6B | 210.41% | |
| 84 | —NEPTUNE WELLNESS SOLUTIONS I | 12,849,706 | $16.6B | 209.21% | |
| 85 | ACRSACLARIS THERAPEUTICS INC | 650,000 | $16.4B | 207.00% | |
| 86 | LPTXEURLEAP THERAPEUTICS INC | 8,476,496 | $16.1B | 203.52% | |
| 87 | —CM LIFE SCIENCES II INC | 1,250,000 | $16.0B | 202.20% | |
| 88 | NBTXNANOBIOTIX SA | 1,059,800 | $15.9B | 201.42% | |
| 89 | —THERAPEUTICS ACQUISITION COR | 1,500,000 | $15.8B | 199.23% | |
| 90 | ACCDEURACCOLADE INC | 345,741 | $15.7B | 198.23% | |
| 91 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 352,804 | $14.2B | 179.50% | |
| 92 | VTRSVIATRIS INC | 1,004,419 | $14.0B | 177.33% | |
| 93 | 698ACHILLES THERAPEUTICS PLC | 755,375 | $12.5B | 157.98% | |
| 94 | CNCEEURCONCERT PHARMACEUTICALS INC | 2,150,641 | $10.7B | 135.61% | |
| 95 | —BCLS ACQUISITION CORP | 1,000,000 | $10.6B | 133.58% | |
| 96 | CLOVCLOVER HEALTH INVESTMENTS CO | 1,500,000 | $10.3B | 130.44% | |
| 97 | HRMYHARMONY BIOSCIENCES HLDGS IN | 311,673 | $10.3B | 130.14% | |
| 98 | —RESEARCH ALLIANCE CORP II | 1,000,000 | $10.3B | 129.53% | |
| 99 | TSHATAYSHA GENE THERAPIES INC | 470,440 | $9.5B | 120.66% | |
| 100 | XENEXENON PHARMACEUTICALS INC | 515,042 | $9.2B | 116.50% |
Page 1 of 2Next